Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs SAMRAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS SAMRAT PHARMA RAYMED LABS/
SAMRAT PHARMA
 
P/E (TTM) x -7.1 4,683.0 - View Chart
P/BV x - 1.6 - View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 RAYMED LABS   SAMRAT PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
SAMRAT PHARMA
Mar-23
RAYMED LABS/
SAMRAT PHARMA
5-Yr Chart
Click to enlarge
High Rs21,250 0.2%   
Low Rs1332 0.4%   
Sales per share (Unadj.) Rs01,005.3 0.0%  
Earnings per share (Unadj.) Rs-0.453.8 -0.7%  
Cash flow per share (Unadj.) Rs-0.455.9 -0.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Avg Dividend yield %00.1 0.0%  
Book value per share (Unadj.) Rs-5.4204.3 -2.6%  
Shares outstanding (eoy) m4.273.09 138.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x00.8-  
Avg P/E ratio x-4.414.7 -30.0%  
P/CF ratio (eoy) x-4.614.1 -32.2%  
Price / Book Value ratio x-0.33.9 -8.5%  
Dividend payout %01.9 -0.0%   
Avg Mkt Cap Rs m82,444 0.3%   
No. of employees `000NANA-   
Total wages/salary Rs m011 3.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m03,106 0.0%  
Other income Rs m05 4.4%   
Total revenues Rs m03,111 0.0%   
Gross profit Rs m-2239 -0.8%  
Depreciation Rs m06 0.8%   
Interest Rs m012 0.0%   
Profit before tax Rs m-2225 -0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m059 0.0%   
Profit after tax Rs m-2166 -1.0%  
Gross profit margin %07.7- 
Effective tax rate %026.2 -0.0%   
Net profit margin %05.4- 
BALANCE SHEET DATA
Current assets Rs m0986 0.0%   
Current liabilities Rs m1528 0.2%   
Net working cap to sales %014.8- 
Current ratio x0.11.9 3.0%  
Inventory Days Days08- 
Debtors Days Days0602- 
Net fixed assets Rs m2175 0.9%   
Share capital Rs m4331 138.3%   
"Free" reserves Rs m-66601 -11.0%   
Net worth Rs m-23631 -3.7%   
Long term debt Rs m00-   
Total assets Rs m21,162 0.1%  
Interest coverage x019.3-  
Debt to equity ratio x00-  
Sales to assets ratio x02.7 0.0%   
Return on assets %-109.515.4 -711.9%  
Return on equity %7.426.3 28.1%  
Return on capital %7.437.6 19.7%  
Exports to sales %04.1-  
Imports to sales %083.3-  
Exports (fob) Rs mNA127 0.0%   
Imports (cif) Rs mNA2,587 0.0%   
Fx inflow Rs m0127 0.0%   
Fx outflow Rs m02,587 0.0%   
Net fx Rs m0-2,460 -0.0%   
CASH FLOW
From Operations Rs m-2-94 1.7%  
From Investments Rs m2-30 -5.5%  
From Financial Activity Rs mNA96 0.0%  
Net Cashflow Rs m0-28 0.0%  

Share Holding

Indian Promoters % 28.4 48.6 58.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 3.2 29.6%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 51.4 139.5%  
Shareholders   1,498 8,065 18.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RAYMED LABS. vs SAMRAT PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RAYMED LABS. vs SAMRAT PHARMA Share Price Performance

Period RAYMED LABS. SAMRAT PHARMA S&P BSE HEALTHCARE
1-Day 0.00% -1.87% 1.18%
1-Month 3.32% -10.12% -0.75%
1-Year 6.86% -2.44% 61.82%
3-Year CAGR 31.90% 34.42% 18.16%
5-Year CAGR -1.90% 38.09% 19.79%

* Compound Annual Growth Rate

Here are more details on the RAYMED LABS. share price and the SAMRAT PHARMA share price.

Moving on to shareholding structures...

The promoters of RAYMED LABS. hold a 28.4% stake in the company. In case of SAMRAT PHARMA the stake stands at 48.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RAYMED LABS. and the shareholding pattern of SAMRAT PHARMA.

Finally, a word on dividends...

In the most recent financial year, RAYMED LABS. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

SAMRAT PHARMA paid Rs 1.0, and its dividend payout ratio stood at 1.9%.

You may visit here to review the dividend history of RAYMED LABS., and the dividend history of SAMRAT PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.